{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:15:18Z","timestamp":1787804118358,"version":"build-2784847793"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 82172053"],"award-info":[{"award-number":["Grant No. 82172053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05267-8","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:02:58Z","timestamp":1779688978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of prognostic genes and development of a risk model for pancreatic cancer based on hypoxia- and lipid metabolism-related genes"],"prefix":"10.1007","volume":"17","author":[{"given":"Xiangshu","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"5267_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/bs.apcsb.2024.10.008","volume":"144","author":"K Baghel","year":"2025","unstructured":"Baghel K, Mehrotra S, Prajapati VK. Revolutionizing pancreatic cancer treatment with CAR-T therapy. Adv Protein Chem Struct Biol. 2025;144:331\u201353. https:\/\/doi.org\/10.1016\/bs.apcsb.2024.10.008.","journal-title":"Adv Protein Chem Struct Biol"},{"key":"5267_CR2","doi-asserted-by":"publisher","first-page":"847760","DOI":"10.3389\/fendo.2022.847760","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Zeng N, Ge Y, Wang D, Qin X, Zhang W, et al. Identification of the shared gene signatures and biological mechanism in type 2 diabetes and pancreatic cancer. Front Endocrinol. 2022;13:847760. https:\/\/doi.org\/10.3389\/fendo.2022.847760.","journal-title":"Front Endocrinol"},{"key":"5267_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5152\/tjg.2024.24544","volume":"36","author":"P Wenzel","year":"2025","unstructured":"Wenzel P, Mogler C, G\u00f6rg\u00fcl\u00fc K, Alg\u00fcl H. Pancreatic cancer: Current concepts, trends, and future directions. Turk J Gastroenterol. 2025;36:69\u201381. https:\/\/doi.org\/10.5152\/tjg.2024.24544.","journal-title":"Turk J Gastroenterol"},{"key":"5267_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","volume":"520","author":"J Cai","year":"2021","unstructured":"Cai J, Chen H, Lu M, Zhang Y, Lu B, You L, et al. Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis. Cancer Lett. 2021;520:1\u201311. https:\/\/doi.org\/10.1016\/j.canlet.2021.06.027.","journal-title":"Cancer Lett"},{"key":"5267_CR5","doi-asserted-by":"publisher","first-page":"e7454","DOI":"10.1002\/cam4.7454","volume":"13","author":"Y Yanjun","year":"2024","unstructured":"Yanjun Y, Jing Z, Yifei S, Gangzhao G, Chenxin Y, Qiang W, et al. Trace elements in pancreatic cancer. Cancer Med. 2024;13:e7454. https:\/\/doi.org\/10.1002\/cam4.7454.","journal-title":"Cancer Med"},{"key":"5267_CR6","doi-asserted-by":"publisher","first-page":"1563725","DOI":"10.3389\/fimmu.2025.1563725","volume":"16","author":"Z Fan","year":"2025","unstructured":"Fan Z, Xiao Y, Du Y, Zhang Y, Zhou W. Pancreatic cancer subtyping - the keystone of precision treatment. Front Immunol. 2025;16:1563725. https:\/\/doi.org\/10.3389\/fimmu.2025.1563725.","journal-title":"Front Immunol"},{"key":"5267_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s10142-024-01356-5","volume":"24","author":"S Zhao","year":"2024","unstructured":"Zhao S, Zhang P, Niu S, Xie J, Liu Y, Liu Y, et al. Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data. Funct Integr Genomics. 2024;24:72. https:\/\/doi.org\/10.1007\/s10142-024-01356-5.","journal-title":"Funct Integr Genomics"},{"key":"5267_CR8","doi-asserted-by":"publisher","first-page":"1132424","DOI":"10.3389\/fonc.2023.1132424","volume":"13","author":"J Chen","year":"2023","unstructured":"Chen J, Liu Z, Wu Z, Li W, Tan X. Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer. Front Oncol. 2023;13:1132424. https:\/\/doi.org\/10.3389\/fonc.2023.1132424.","journal-title":"Front Oncol"},{"key":"5267_CR9","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.21037\/tcr-23-1365","volume":"13","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Huang B, Zhang Q, Yu Y, Xiao J. Modeling of new markers for the diagnosis and prognosis of pancreatic cancer based on the transition from inflammation to cancer. Transl Cancer Res. 2024;13:1425\u201342. https:\/\/doi.org\/10.21037\/tcr-23-1365.","journal-title":"Transl Cancer Res"},{"key":"5267_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11011-021-00796-3","volume":"37","author":"X Wang","year":"2022","unstructured":"Wang X, Cui L, Ji X. Cognitive impairment caused by hypoxia: From clinical evidences to molecular mechanisms. Metab Brain Dis. 2022;37:51\u201366. https:\/\/doi.org\/10.1007\/s11011-021-00796-3.","journal-title":"Metab Brain Dis"},{"key":"5267_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0118761429308567240806111848","volume":"17","author":"R Khodashahi","year":"2024","unstructured":"Khodashahi R, Tavakkoli M, Ferns GA, Feyzmohammadi L, Mirzaei AH, Aliakbarian M, et al. Adipose tissue dysfunction following trauma and hypoxia increases the risk of post-surgical adhesion: Potential for therapeutic interventions. Curr Mol Pharmacol. 2024;17:1\u20136. https:\/\/doi.org\/10.2174\/0118761429308567240806111848.","journal-title":"Curr Mol Pharmacol"},{"key":"5267_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/s12967-024-05391-5","volume":"22","author":"A Huang","year":"2024","unstructured":"Huang A, Sun Z, Hong H, Yang Y, Chen J, Gao Z, et al. Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer. J Transl Med. 2024;22:587. https:\/\/doi.org\/10.1186\/s12967-024-05391-5.","journal-title":"J Transl Med"},{"key":"5267_CR13","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1038\/s41388-023-02869-2","volume":"42","author":"P Fan","year":"2023","unstructured":"Fan P, Zhang N, Candi E, Agostini M, Piacentini M, Shi Y, et al. Alleviating hypoxia to improve cancer immunotherapy. Oncogene. 2023;42:3591\u2013604. https:\/\/doi.org\/10.1038\/s41388-023-02869-2.","journal-title":"Oncogene"},{"key":"5267_CR14","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","volume":"81","author":"H Yoon","year":"2021","unstructured":"Yoon H, Shaw JL, Haigis MC, Greka A. Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity. Mol Cell. 2021;81:3708\u201330. https:\/\/doi.org\/10.1016\/j.molcel.2021.08.027.","journal-title":"Mol Cell"},{"key":"5267_CR15","doi-asserted-by":"publisher","first-page":"2100396","DOI":"10.1002\/adbi.202100396","volume":"5","author":"Z Lin","year":"2021","unstructured":"Lin Z, Liu J, Kang R, Yang M, Tang D. Lipid metabolism in ferroptosis. Adv Biol. 2021;5:2100396. https:\/\/doi.org\/10.1002\/adbi.202100396.","journal-title":"Adv Biol"},{"key":"5267_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2017.05.002","volume":"401","author":"Q Liu","year":"2017","unstructured":"Liu Q, Luo Q, Halim A, Song G. Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer. Cancer Lett. 2017;401:39\u201345. https:\/\/doi.org\/10.1016\/j.canlet.2017.05.002.","journal-title":"Cancer Lett"},{"key":"5267_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12967-024-04870-z","volume":"22","author":"D Gu","year":"2024","unstructured":"Gu D, Ye M, Zhu G, Bai J, Chen J, Yan L, et al. Hypoxia upregulating ACSS2 enhances lipid metabolism reprogramming through HMGCS1 mediated PI3K\/AKT\/mTOR pathway to promote the progression of pancreatic neuroendocrine neoplasms. J Transl Med. 2024;22:93. https:\/\/doi.org\/10.1186\/s12967-024-04870-z.","journal-title":"J Transl Med"},{"key":"5267_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40170-025-00389-z","volume":"13","author":"X Han","year":"2025","unstructured":"Han X, Kim LC, Lesner NP, Cai X, Van Le TN, Simon MC. Glutaminase inhibition ameliorates cancer-associated fibroblast lipid support of pancreatic cancer cell growth. Cancer Metab. 2025;13:38. https:\/\/doi.org\/10.1186\/s40170-025-00389-z.","journal-title":"Cancer Metab"},{"key":"5267_CR19","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3390\/biom12101533","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Liang X, Che G, Chen Y, Luo L, Liu K, et al. Molecular classification of genes associated with hypoxic lipid metabolism in pancreatic cancer. Biomolecules. 2022;12:1533. https:\/\/doi.org\/10.3390\/biom12101533.","journal-title":"Biomolecules"},{"key":"5267_CR20","doi-asserted-by":"publisher","first-page":"159398","DOI":"10.1016\/j.bbalip.2023.159398","volume":"1868","author":"PK Agarwala","year":"2023","unstructured":"Agarwala PK, Nie S, Reid GE, Kapoor S. Global lipid remodelling by hypoxia aggravates migratory potential in pancreatic cancer while maintaining plasma membrane homeostasis. Biochim Biophys Acta Mol Cell Biol Lipids. 2023;1868:159398. https:\/\/doi.org\/10.1016\/j.bbalip.2023.159398.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"5267_CR21","doi-asserted-by":"publisher","first-page":"11683","DOI":"10.1038\/s41598-025-96855-1","volume":"15","author":"Z Deng","year":"2025","unstructured":"Deng Z, Yang Z, Li L, Zeng G, Meng Z, Liu R. A lipid metabolism related gene signature predicts postoperative recurrence in pancreatic cancer through multicenter cohort validation. Sci Rep. 2025;15:11683. https:\/\/doi.org\/10.1038\/s41598-025-96855-1.","journal-title":"Sci Rep"},{"key":"5267_CR22","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1039\/d5mo00111k","volume":"21","author":"PK Agarwala","year":"2025","unstructured":"Agarwala PK, Singh A, Srivastava S, Kapoor S. Hypoxia-induced alterations in lipid polyunsaturation and associated proteins drive aggressive metastasis in pancreatic cancer via the PPAR\/hypoxia pathway. Mol Omics. 2025;21:736\u201346. https:\/\/doi.org\/10.1039\/d5mo00111k.","journal-title":"Mol Omics"},{"key":"5267_CR23","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.7150\/ijbs.104598","volume":"21","author":"Y Yin","year":"2025","unstructured":"Yin Y, Sun Y, Yao H, Yu F, Jia Q, Hu C, et al. TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the \u03b2-catenin-c-MYC-GLUT1 axis. Int J Biol Sci. 2025;21:1932\u201348. https:\/\/doi.org\/10.7150\/ijbs.104598.","journal-title":"Int J Biol Sci"},{"key":"5267_CR24","doi-asserted-by":"publisher","first-page":"42268","DOI":"10.1038\/s41598-025-26358-6","volume":"15","author":"X Wang","year":"2025","unstructured":"Wang X, Wang X, Ying B. A autophagy related gene signature to predict the prognosis of pancreatic carcinoma and tumor immune microenvironment evaluation. Sci Rep. 2025;15:42268. https:\/\/doi.org\/10.1038\/s41598-025-26358-6.","journal-title":"Sci Rep"},{"key":"5267_CR25","doi-asserted-by":"publisher","first-page":"12493","DOI":"10.18632\/aging.202922","volume":"13","author":"H Lin","year":"2021","unstructured":"Lin H, Hu C, Zheng S, Zhang X, Chen R, Zhou Q. A novel gene signature for prognosis prediction and chemotherapy response in patients with pancreatic cancer. Aging. 2021;13:12493\u2013513. https:\/\/doi.org\/10.18632\/aging.202922.","journal-title":"Aging"},{"key":"5267_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12865-025-00733-4","volume":"26","author":"Z Deng","year":"2025","unstructured":"Deng Z, Li L, Yang Z, Zeng G, Liu R. Integrated analysis of polytranscriptomics reveals TNFSF ligand genes in pancreatic cancer prognosis and immune regulation. BMC Immunol. 2025;26:50. https:\/\/doi.org\/10.1186\/s12865-025-00733-4.","journal-title":"BMC Immunol"},{"key":"5267_CR27","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1038\/s41598-025-85809-2","volume":"15","author":"S Huang","year":"2025","unstructured":"Huang S, Wang H, Cao J, Pang Q. Hypoxia and lipid metabolism related genes drive proliferation migration and immune infiltration mechanisms in colorectal cancer subtyping. Sci Rep. 2025;15:2394. https:\/\/doi.org\/10.1038\/s41598-025-85809-2.","journal-title":"Sci Rep"},{"key":"5267_CR28","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"5267_CR29","doi-asserted-by":"publisher","first-page":"2477301","DOI":"10.1080\/07853890.2025.2477301","volume":"57","author":"W Zhou","year":"2025","unstructured":"Zhou W, Li H, Zhang J, Liu C, Liu D, Chen X, et al. Identification and mechanism analysis of biomarkers related to butyrate metabolism in COVID-19 patients. Ann Med. 2025;57:2477301. https:\/\/doi.org\/10.1080\/07853890.2025.2477301.","journal-title":"Ann Med"},{"key":"5267_CR30","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov. 2021;2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","journal-title":"Innov"},{"key":"5267_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.scog.2017.10.001","volume":"11","author":"IS Ramsay","year":"2017","unstructured":"Ramsay IS, Ma S, Fisher M, Loewy RL, Ragland JD, Niendam T, et al. Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training. Schizophr Res Cogn. 2017;11:1\u20135. https:\/\/doi.org\/10.1016\/j.scog.2017.10.001.","journal-title":"Schizophr Res Cogn"},{"key":"5267_CR32","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s10495-023-01868-8","volume":"28","author":"Y Shi","year":"2023","unstructured":"Shi Y, Wang Y, Dong H, Niu K, Zhang W, Feng K, et al. Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: Novel perspective to mRNA vaccines and personalized immunotherapy. Apoptosis. 2023;28:1423\u201335. https:\/\/doi.org\/10.1007\/s10495-023-01868-8.","journal-title":"Apoptosis"},{"key":"5267_CR33","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.1245\/s10434-023-13694-y","volume":"30","author":"S Zhang","year":"2023","unstructured":"Zhang S, Sun L, Cai D, Liu G, Jiang D, Yin J, et al. Development and validation of PET\/CT-based nomogram for preoperative prediction of lymph node status in esophageal squamous cell carcinoma. Ann Surg Oncol. 2023;30:7452\u201360. https:\/\/doi.org\/10.1245\/s10434-023-13694-y.","journal-title":"Ann Surg Oncol"},{"key":"5267_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"5267_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","journal-title":"BMC Bioinformatics"},{"key":"5267_CR36","doi-asserted-by":"publisher","first-page":"841813","DOI":"10.3389\/fendo.2022.841813","volume":"13","author":"Z Meng","year":"2022","unstructured":"Meng Z, Chen Y, Wu W, Yan B, Meng Y, Liang Y, et al. Exploring the immune infiltration landscape and M2 macrophage-related biomarkers of proliferative diabetic retinopathy. Front Endocrinol. 2022;13:841813. https:\/\/doi.org\/10.3389\/fendo.2022.841813.","journal-title":"Front Endocrinol"},{"key":"5267_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/sports11070135","volume":"11","author":"S Orifjon","year":"2023","unstructured":"Orifjon S, Jammatov J, Sousa C, Barros R, Vasconcelos O, Rodrigues P. Translation and adaptation of the adult developmental coordination disorder\/dyspraxia checklist (ADC) into asian uzbekistan. Sports. 2023;11:135. https:\/\/doi.org\/10.3390\/sports11070135.","journal-title":"Sports"},{"key":"5267_CR38","doi-asserted-by":"publisher","first-page":"3143511","DOI":"10.1155\/2022\/3143511","volume":"2022","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang X, Li G, Hao Y, Liu L, Zhang L, et al. A novel necroptosis-associated lncRNA signature can impact the immune status and predict the outcome of breast cancer. J Immunol Res. 2022;2022:3143511. https:\/\/doi.org\/10.1155\/2022\/3143511.","journal-title":"J Immunol Res"},{"key":"5267_CR39","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. https:\/\/doi.org\/10.1038\/ncomms3612.","journal-title":"Nat Commun"},{"key":"5267_CR40","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS, pRRophetic. An R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9:e107468. https:\/\/doi.org\/10.1371\/journal.pone.0107468.","journal-title":"PLoS ONE"},{"key":"5267_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski M, Choudhary S, Hoffman P, Hartman A, et al. Dictionary learning for integrative, multimodal, and massively scalable single-cell analysis. Nat Biotechnol. 2024;42:293\u2013304. https:\/\/doi.org\/10.1038\/s41587-023-01767-y.","journal-title":"Nat Biotechnol"},{"key":"5267_CR42","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng J, Sun B-F, Chen C-Y, Zhou J-Y, Chen Y-S, Chen H, et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 2019;29:725\u201338. https:\/\/doi.org\/10.1038\/s41422-019-0195-y.","journal-title":"Cell Res"},{"key":"5267_CR43","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12672-025-02293-w","volume":"16","author":"C Zhang","year":"2025","unstructured":"Zhang C, Tang R, Yang J, Chen Y, Li Y, Zhou C, et al. Identification of DNA damage and repair gene-related markers in pancreatic ductal adenocarcinoma by single-cell and bulk RNA sequencing. Discov Oncol. 2025;16:491. https:\/\/doi.org\/10.1007\/s12672-025-02293-w.","journal-title":"Discov Oncol"},{"key":"5267_CR44","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1074\/mcp.TIR120.002155","volume":"19","author":"J Griss","year":"2020","unstructured":"Griss J, Viteri G, Sidiropoulos K, Nguyen V, Fabregat A, Hermjakob H. ReactomeGSA - efficient multi-omics comparative pathway analysis. Mol Cell Proteom. 2020;19:2115\u201324. https:\/\/doi.org\/10.1074\/mcp.TIR120.002155.","journal-title":"Mol Cell Proteom"},{"key":"5267_CR45","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yang S, Ma J, Chen Z, Song G, Rao D, et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov. 2022;12:134\u201353. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0316.","journal-title":"Cancer Discov"},{"key":"5267_CR46","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan C-H, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12:1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","journal-title":"Nat Commun"},{"key":"5267_CR47","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s42003-025-08316-0","volume":"8","author":"H Wang","year":"2025","unstructured":"Wang H, He X, Ma M, Dou T, Wei Y, Rux D, et al. Integrating spatial and single-cell transcriptomics to characterize mouse long bone fracture healing process. Commun Biol. 2025;8:887. https:\/\/doi.org\/10.1038\/s42003-025-08316-0.","journal-title":"Commun Biol"},{"key":"5267_CR48","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41419-024-06930-0","volume":"15","author":"H Wu","year":"2024","unstructured":"Wu H, Fu M, Wu M, Cao Z, Zhang Q, Liu Z. Emerging mechanisms and promising approaches in pancreatic cancer metabolism. Cell Death Dis. 2024;15:553. https:\/\/doi.org\/10.1038\/s41419-024-06930-0.","journal-title":"Cell Death Dis"},{"key":"5267_CR49","doi-asserted-by":"publisher","first-page":"10884","DOI":"10.12998\/wjcc.v9.i35.10884","volume":"9","author":"H Xu","year":"2021","unstructured":"Xu H, Sun J, Zhou L, Du Q-C, Zhu H-Y, Chen Y, et al. Development of a lipid metabolism-related gene model to predict prognosis in patients with pancreatic cancer. World J Clin Cases. 2021;9:10884\u201398. https:\/\/doi.org\/10.12998\/wjcc.v9.i35.10884.","journal-title":"World J Clin Cases"},{"key":"5267_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.18632\/oncotarget.260","volume":"2","author":"IU Agoulnik","year":"2011","unstructured":"Agoulnik IU, Hodgson MC, Bowden WA, Ittmann MM. INPP4B: The new kid on the PI3K block. Oncotarget. 2011;2:321\u20138. https:\/\/doi.org\/10.18632\/oncotarget.260.","journal-title":"Oncotarget"},{"key":"5267_CR51","doi-asserted-by":"publisher","first-page":"2270097","DOI":"10.1155\/2023\/2270097","volume":"2023","author":"N Miroschnikov","year":"2023","unstructured":"Miroschnikov N, Dr\u00e4ger O, Van Meenen D, Metz K, Budeus B, D\u00fcnker N, et al. Tumor suppressor role of INPP4B in chemoresistant retinoblastoma. J Oncol. 2023;2023:2270097. https:\/\/doi.org\/10.1155\/2023\/2270097.","journal-title":"J Oncol"},{"key":"5267_CR52","doi-asserted-by":"publisher","first-page":"7201","DOI":"10.7150\/jca.58397","volume":"12","author":"Y Wu","year":"2021","unstructured":"Wu Y, Wang X, Lu Y, Wang H, Wang M, You Y, et al. INPP4B exerts a dual role in gastric cancer progression and prognosis. J Cancer. 2021;12:7201\u201313. https:\/\/doi.org\/10.7150\/jca.58397.","journal-title":"J Cancer"},{"key":"5267_CR53","doi-asserted-by":"publisher","first-page":"110716","DOI":"10.1016\/j.jbc.2025.110716","volume":"301","author":"GT Saffi","year":"2025","unstructured":"Saffi GT, Kleine N, Salmena L. The lipid phosphatase INPP4B controls pancreatic cancer cell migration and invasion by regulating fibronectin exocytosis. J Biol Chem. 2025;301:110716. https:\/\/doi.org\/10.1016\/j.jbc.2025.110716.","journal-title":"J Biol Chem"},{"key":"5267_CR54","doi-asserted-by":"publisher","first-page":"8287","DOI":"10.2147\/OTT.S223221","volume":"12","author":"S Zhai","year":"2019","unstructured":"Zhai S, Liu Y, Lu X, Qian H, Tang X, Cheng X, et al. INPP4B as a prognostic and diagnostic marker regulates cell growth of pancreatic cancer via activating AKT. OncoTargets Ther. 2019;12:8287\u201399. https:\/\/doi.org\/10.2147\/OTT.S223221.","journal-title":"OncoTargets Ther"},{"key":"5267_CR55","doi-asserted-by":"publisher","first-page":"e202401012","DOI":"10.1083\/jcb.202401012","volume":"223","author":"GT Saffi","year":"2024","unstructured":"Saffi GT, To L, Kleine N, Melo CMP, Chen K, Genc G, et al. INPP4B promotes PDAC aggressiveness via PIKfyve and TRPML-1\u2013mediated lysosomal exocytosis. J Cell Biol. 2024;223:e202401012. https:\/\/doi.org\/10.1083\/jcb.202401012.","journal-title":"J Cell Biol"},{"key":"5267_CR56","doi-asserted-by":"publisher","first-page":"9125","DOI":"10.1111\/jcmm.15549","volume":"24","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhu X, Qiao X, Gu X, Xue J, Han Y, et al. LIPH promotes metastasis by enriching stem-like cells in triple\u2010negative breast cancer. J Cell Mol Med. 2020;24:9125\u201334. https:\/\/doi.org\/10.1111\/jcmm.15549.","journal-title":"J Cell Mol Med"},{"key":"5267_CR57","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2147\/CMAR.S183355","volume":"11","author":"Y Li","year":"2019","unstructured":"Li Y, Zhou X, Zhang Q, Chen E, Sun Y, Ye D, et al. Lipase member H is a downstream molecular target of hypoxia inducible factor-1\u03b1 and promotes papillary thyroid carcinoma cell migration in BCPAP and KTC-1 cell lines. Cancer Manag Res. 2019;11:931\u201341. https:\/\/doi.org\/10.2147\/CMAR.S183355.","journal-title":"Cancer Manag Res"},{"key":"5267_CR58","doi-asserted-by":"publisher","first-page":"7613","DOI":"10.2147\/IJGM.S332233","volume":"14","author":"P Gao","year":"2021","unstructured":"Gao P, Liu Q, Ai B, Fang Y, Wang Z, Wang J. Prognostic value and clinical significance of LIPH in breast cancer. Int J Gen Med. 2021;14:7613\u201323. https:\/\/doi.org\/10.2147\/IJGM.S332233.","journal-title":"Int J Gen Med"},{"key":"5267_CR59","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1186\/s12967-023-04702-6","volume":"21","author":"L Han","year":"2023","unstructured":"Han L, Jiang Y, Shi M, Gan L, Wu Z, Xue M, et al. LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA\/LPAR axis and maintaining ALDOA stability. J Transl Med. 2023;21:838. https:\/\/doi.org\/10.1186\/s12967-023-04702-6.","journal-title":"J Transl Med"},{"key":"5267_CR60","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00262-021-03019-x","volume":"71","author":"H Zhuang","year":"2022","unstructured":"Zhuang H, Chen X, Wang Y, Huang S, Chen B, Zhang C, et al. Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seq. Cancer Immunol Immunother CII. 2022;71:601\u201312. https:\/\/doi.org\/10.1007\/s00262-021-03019-x.","journal-title":"Cancer Immunol Immunother CII"},{"key":"5267_CR61","doi-asserted-by":"publisher","first-page":"e24287","DOI":"10.1016\/j.heliyon.2024.e24287","volume":"10","author":"M Zhang","year":"2024","unstructured":"Zhang M, Jiang L, Liu X-Y, Liu F-X, Zhang H, Zhang Y-J, et al. KLK10\/LIPH\/PARD6B\/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA network. Heliyon. 2024;10:e24287. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24287.","journal-title":"Heliyon"},{"key":"5267_CR62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/cac2.12386","volume":"43","author":"L Zhang","year":"2022","unstructured":"Zhang L, Li Q, Yang J, Xu P, Xuan Z, Xu J, et al. Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination\/degradation of STAT1 in a GTP binding\u2010dependent modality. Cancer Commun. 2022;43:123\u201349. https:\/\/doi.org\/10.1002\/cac2.12386.","journal-title":"Cancer Commun"},{"key":"5267_CR63","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jhep.2024.12.038","volume":"83","author":"R Dong","year":"2025","unstructured":"Dong R, Wang T, Dong W, Zhang H, Li Y, Tao R, et al. TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway. J Hepatol. 2025;83:105\u201318. https:\/\/doi.org\/10.1016\/j.jhep.2024.12.038.","journal-title":"J Hepatol"},{"key":"5267_CR64","doi-asserted-by":"publisher","first-page":"218396","DOI":"10.1016\/j.canlet.2026.218396","volume":"645","author":"T Ling","year":"2026","unstructured":"Ling T, Zhang W, Cai H, Kien TT, Yan T, Wang J, et al. TGM2-mediated serotonylation in tumor endothelial cells promotes angiogenesis and tumor growth in colorectal cancer. Cancer Lett. 2026;645:218396. https:\/\/doi.org\/10.1016\/j.canlet.2026.218396.","journal-title":"Cancer Lett"},{"key":"5267_CR65","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.trsl.2024.05.006","volume":"271","author":"S-S Li","year":"2024","unstructured":"Li S-S, Liu Q-J, Bao J-X, Lu M, Deng B-Q, Li W-W, et al. Counteracting TGM2 by a fibroin peptide ameliorated adriamycin-induced nephropathy via regulation of lipid metabolism through PANX1-PPAR \u03b1\/PANK1 pathway. Transl Res. 2024;271:26\u201339. https:\/\/doi.org\/10.1016\/j.trsl.2024.05.006.","journal-title":"Transl Res"},{"key":"5267_CR66","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.1038\/s41467-025-61197-z","volume":"16","author":"S Lin","year":"2025","unstructured":"Lin S, Tan S, Peng Y, Tulamaiti A, Du W, Ding K, et al. Histone serotonylation promotes pancreatic cancer development via lipid metabolism remodeling. Nat Commun. 2025;16:5947. https:\/\/doi.org\/10.1038\/s41467-025-61197-z.","journal-title":"Nat Commun"},{"key":"5267_CR67","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12885-021-08158-z","volume":"21","author":"F Wang","year":"2021","unstructured":"Wang F, Wang L, Qu C, Chen L, Geng Y, Cheng C, et al. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated akt\/mTOR signaling. BMC Cancer. 2021;21:396. https:\/\/doi.org\/10.1186\/s12885-021-08158-z.","journal-title":"BMC Cancer"},{"key":"5267_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41420-025-02922-x","volume":"12","author":"K Ye","year":"2026","unstructured":"Ye K, Zhou S, Gong X, Zhu Z, Xiao M, Liang S. TGM2-P2RX7 loop promotes gemcitabine resistance in pancreatic cancer by modulating glutamine metabolism and mitophagy. Cell Death Discov. 2026;12:2. https:\/\/doi.org\/10.1038\/s41420-025-02922-x.","journal-title":"Cell Death Discov"},{"key":"5267_CR69","doi-asserted-by":"publisher","first-page":"e010579","DOI":"10.1136\/jitc-2024-010579","volume":"13","author":"A Lahusen","year":"2025","unstructured":"Lahusen A, Minh\u00f6fer N, Lohse K-A, Blechner C, Lindenmayer J, Eiseler T, et al. Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokines. J Immunother Cancer. 2025;13:e010579. https:\/\/doi.org\/10.1136\/jitc-2024-010579.","journal-title":"J Immunother Cancer"},{"key":"5267_CR70","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3892\/mmr.2021.12289","volume":"24","author":"K Zhan","year":"2021","unstructured":"Zhan K, Bai Y, Liao S, Chen H, Kuang L, Luo Q, et al. Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma. Mol Med Rep. 2021;24:650. https:\/\/doi.org\/10.3892\/mmr.2021.12289.","journal-title":"Mol Med Rep"},{"key":"5267_CR71","doi-asserted-by":"publisher","first-page":"870721","DOI":"10.3389\/fonc.2022.870721","volume":"12","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Li X, Guan A, Zhou H, Zhu Y, Wang R, et al. EPHX2 inhibits colon cancer progression by promoting fatty acid degradation. Front Oncol. 2022;12:870721. https:\/\/doi.org\/10.3389\/fonc.2022.870721.","journal-title":"Front Oncol"},{"key":"5267_CR72","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1074\/jbc.RA117.000298","volume":"293","author":"ML Edin","year":"2018","unstructured":"Edin ML, Hamedani BG, Gruzdev A, Graves JP, Lih FB, Arbes SJ, et al. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia. J Biol Chem. 2018;293:3281\u201392. https:\/\/doi.org\/10.1074\/jbc.RA117.000298.","journal-title":"J Biol Chem"},{"key":"5267_CR73","doi-asserted-by":"publisher","first-page":"1541429","DOI":"10.3389\/fonc.2025.1541429","volume":"15","author":"B Guan","year":"2025","unstructured":"Guan B, Huang C, He J, Shan W, Cui D, Li X, et al. EPHX2 overexpression deters the advancement of clear cell renal cell carcinoma via lipid metabolism reprogramming. Front Oncol. 2025;15:1541429. https:\/\/doi.org\/10.3389\/fonc.2025.1541429.","journal-title":"Front Oncol"},{"key":"5267_CR74","doi-asserted-by":"publisher","first-page":"111798","DOI":"10.1016\/j.biopha.2021.111798","volume":"141","author":"X Hao","year":"2021","unstructured":"Hao X, Ren Y, Feng M, Wang Q, Wang Y. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more. Biomed Pharmacother. 2021;141:111798. https:\/\/doi.org\/10.1016\/j.biopha.2021.111798.","journal-title":"Biomed Pharmacother"},{"key":"5267_CR75","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00018-019-03278-z","volume":"77","author":"J Yang","year":"2019","unstructured":"Yang J, Ren B, Yang G, Wang H, Chen G, You L, et al. The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci. 2019;77:305\u201321. https:\/\/doi.org\/10.1007\/s00018-019-03278-z.","journal-title":"Cell Mol Life Sci"},{"key":"5267_CR76","first-page":"861","volume":"12","author":"X Chang","year":"2022","unstructured":"Chang X, Liu X, Wang H, Yang X, Gu Y. Glycolysis in the progression of pancreatic cancer. Am J Cancer Res. 2022;12:861\u201372.","journal-title":"Am J Cancer Res"},{"key":"5267_CR77","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1186\/s12967-024-05598-6","volume":"22","author":"M Mascaraque","year":"2024","unstructured":"Mascaraque M, Courtois S, Royo-Garc\u00eda A, Barneda D, Stoian AM, Villaoslada I, et al. Fatty acid oxidation is critical for the tumorigenic potential and chemoresistance of pancreatic cancer stem cells. J Transl Med. 2024;22:797. https:\/\/doi.org\/10.1186\/s12967-024-05598-6.","journal-title":"J Transl Med"},{"key":"5267_CR78","doi-asserted-by":"publisher","first-page":"926230","DOI":"10.3389\/fonc.2022.926230","volume":"12","author":"Q Wang","year":"2022","unstructured":"Wang Q, Wang H, Ding Y, Wan M, Xu M. The role of adipokines in pancreatic cancer. Front Oncol. 2022;12:926230. https:\/\/doi.org\/10.3389\/fonc.2022.926230.","journal-title":"Front Oncol"},{"key":"5267_CR79","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3892\/or.2023.8578","volume":"50","author":"Z Cai","year":"2023","unstructured":"Cai Z, Li Y, Ma M, Wang L, Wang H, Liu M, et al. Adipocytes promote pancreatic cancer migration and invasion through fatty acid metabolic reprogramming. Oncol Rep. 2023;50:141. https:\/\/doi.org\/10.3892\/or.2023.8578.","journal-title":"Oncol Rep"},{"key":"5267_CR80","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng L, Qin S, Si W, Wang A, Xing B, Gao R, et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science. 2021;374:abe6474. https:\/\/doi.org\/10.1126\/science.abe6474.","journal-title":"Science"},{"key":"5267_CR81","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","volume":"4","author":"DE Speiser","year":"2023","unstructured":"Speiser DE, Chijioke O, Schaeuble K, M\u00fcnz C. CD4\u2009+\u2009T cells in cancer. Nat Cancer. 2023;4:317\u201329. https:\/\/doi.org\/10.1038\/s43018-023-00521-2.","journal-title":"Nat Cancer"},{"key":"5267_CR82","doi-asserted-by":"publisher","first-page":"eabq0712","DOI":"10.1126\/sciadv.abq0712","volume":"9","author":"SX Shi","year":"2023","unstructured":"Shi SX, Xiu Y, Li Y, Yuan M, Shi K, Liu Q, et al. CD4\u2009+\u2009T cells aggravate hemorrhagic brain injury. Sci Adv. 2023;9:eabq0712. https:\/\/doi.org\/10.1126\/sciadv.abq0712.","journal-title":"Sci Adv"},{"key":"5267_CR83","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.7150\/thno.83495","volume":"13","author":"S Liu","year":"2023","unstructured":"Liu S, Li F, Ma Q, Du M, Wang H, Zhu Y, et al. OX40L-armed oncolytic virus boosts T-cell response and remodels tumor microenvironment for pancreatic cancer treatment. Theranostics. 2023;13:4016\u201329. https:\/\/doi.org\/10.7150\/thno.83495.","journal-title":"Theranostics"},{"key":"5267_CR84","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.4049\/jimmunol.170.6.2940","volume":"170","author":"JM Blander","year":"2003","unstructured":"Blander JM, Sant\u2019Angelo DB, Metz D, Kim S-W, Flavell RA, Bottomly K, et al. A pool of central memory-like CD4 T cells contains effector memory precursors. J Immunol. 2003;170:2940\u20138. https:\/\/doi.org\/10.4049\/jimmunol.170.6.2940.","journal-title":"J Immunol"},{"key":"5267_CR85","doi-asserted-by":"publisher","first-page":"2002054","DOI":"10.1002\/adma.202002054","volume":"32","author":"Y Xia","year":"2020","unstructured":"Xia Y, Rao L, Yao H, Wang Z, Ning P, Chen X. Engineering macrophages for cancer immunotherapy and drug delivery. Adv Mater. 2020;32:2002054. https:\/\/doi.org\/10.1002\/adma.202002054.","journal-title":"Adv Mater"},{"key":"5267_CR86","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. Int J Mol Sci. 2021;22:6995. https:\/\/doi.org\/10.3390\/ijms22136995.","journal-title":"Int J Mol Sci"},{"key":"5267_CR87","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2024.03.009","volume":"42","author":"M Liu","year":"2024","unstructured":"Liu M, Ren Y, Zhou Z, Yang J, Shi X, Cai Y, et al. The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia. Cancer Cell. 2024;42:885\u2013e9034. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.009.","journal-title":"Cancer Cell"},{"key":"5267_CR88","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","volume":"8","author":"F Shan","year":"2022","unstructured":"Shan F, Somasundaram A, Bruno TC, Workman CJ, Vignali DAA. Therapeutic targeting of regulatory T cells in cancer. Trends Cancer. 2022;8:944\u201361. https:\/\/doi.org\/10.1016\/j.trecan.2022.06.008.","journal-title":"Trends Cancer"},{"key":"5267_CR89","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6:362. https:\/\/doi.org\/10.1038\/s41392-021-00670-9.","journal-title":"Signal Transduct Target Ther"},{"key":"5267_CR90","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.3748\/wjg.v22.i12.3471","volume":"22","author":"AK Chan","year":"2016","unstructured":"Chan AK, Bruce JI, Siriwardena AK. Glucose metabolic phenotype of pancreatic cancer. World J Gastroenterol. 2016;22:3471\u201385. https:\/\/doi.org\/10.3748\/wjg.v22.i12.3471.","journal-title":"World J Gastroenterol"},{"key":"5267_CR91","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1016\/j.yexcr.2007.06.013","volume":"313","author":"M Natsuizaka","year":"2007","unstructured":"Natsuizaka M, Ozasa M, Darmanin S, Miyamoto M, Kondo S, Kamada S, et al. Synergistic up-regulation of hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia. Exp Cell Res. 2007;313:3337\u201348. https:\/\/doi.org\/10.1016\/j.yexcr.2007.06.013.","journal-title":"Exp Cell Res"},{"key":"5267_CR92","doi-asserted-by":"publisher","first-page":"6807","DOI":"10.1038\/srep06807","volume":"4","author":"J Li","year":"2014","unstructured":"Li J, Cheng J-X. Direct visualization of de novo lipogenesis in single living cells. Sci Rep. 2014;4:6807. https:\/\/doi.org\/10.1038\/srep06807.","journal-title":"Sci Rep"},{"key":"5267_CR93","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1158\/0008-5472.CAN-06-3292","volume":"67","author":"M Winner","year":"2007","unstructured":"Winner M, Koong AC, Rendon BE, Zundel W, Mitchell RA. Amplification of tumor hypoxic responses by macrophage migration inhibitory factor\u2013dependent hypoxia-inducible factor stabilization. Cancer Res. 2007;67:186\u201393. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3292.","journal-title":"Cancer Res"},{"key":"5267_CR94","doi-asserted-by":"publisher","first-page":"638950","DOI":"10.3389\/fphar.2021.638950","volume":"12","author":"Y Wen","year":"2021","unstructured":"Wen Y, Cai W, Yang J, Fu X, Putha L, Xia Q, et al. Targeting macrophage migration inhibitory factor in acute pancreatitis and pancreatic cancer. Front Pharmacol. 2021;12:638950. https:\/\/doi.org\/10.3389\/fphar.2021.638950.","journal-title":"Front Pharmacol"},{"key":"5267_CR95","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/ijc.27736","volume":"132","author":"N Funamizu","year":"2013","unstructured":"Funamizu N, Hu C, Lacy C, Schetter A, Zhang G, He P, et al. Macrophage migration inhibitory factor (MIF) induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma. Int J Cancer. 2013;132:785\u201394. https:\/\/doi.org\/10.1002\/ijc.27736.","journal-title":"Int J Cancer"},{"key":"5267_CR96","doi-asserted-by":"publisher","first-page":"8730","DOI":"10.4049\/jimmunol.177.12.8730","volume":"177","author":"KL Meyer-Siegler","year":"2006","unstructured":"Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol. 2006;177:8730\u20139. https:\/\/doi.org\/10.4049\/jimmunol.177.12.8730.","journal-title":"J Immunol"},{"key":"5267_CR97","doi-asserted-by":"publisher","first-page":"19740","DOI":"10.1074\/jbc.RA118.003935","volume":"293","author":"R De","year":"2018","unstructured":"De R, Sarkar S, Mazumder S, Debsharma S, Siddiqui AA, Saha SJ, et al. Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74\u2013NF-\u03baB signaling. J Biol Chem. 2018;293:19740\u201360. https:\/\/doi.org\/10.1074\/jbc.RA118.003935.","journal-title":"J Biol Chem"},{"key":"5267_CR98","doi-asserted-by":"publisher","first-page":"117822342412763","DOI":"10.1177\/11782234241276310","volume":"18","author":"A Khezrian","year":"2024","unstructured":"Khezrian A, Shojaeian A, Khaghani Boroujeni A, Amini R. Therapeutic opportunities in breast cancer by targeting macrophage migration inhibitory factor as a pleiotropic cytokine. Breast Cancer Basic Clin Res. 2024;18:11782234241276310. https:\/\/doi.org\/10.1177\/11782234241276310.","journal-title":"Breast Cancer Basic Clin Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05267-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05267-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05267-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:02:28Z","timestamp":1784548948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05267-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5267"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05267-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No primary patient samples, animal experiments, or human subjects were involved in this research. Therefore, ethical approval was not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript does not include data from any individual person in any form.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1044"}}